| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |